StockData
Olema Oncology, Inc. logo

Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.22−0.14 (-1.90%)

Close on Nov 17, 2026Market cap $631.73MP/E –Yield –

Olema Oncology total assets

Total assets on the balance sheet at the end of each period.

Olema Oncology's total assets was $486.58M at Jun 30, 2026. For fiscal 2025 it was $533.43M, up 18.3% from the year before. The highest annual figure on record is $533.43M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$533.43M+18.3%
FY2024Dec 31, 2024$450.98M+62.8%
FY2023Dec 31, 2023$276.95M+28.4%
FY2022Dec 31, 2022$215.65M-27.1%
FY2021Dec 31, 2021$295.95M-13.6%
FY2020Dec 31, 2020$342.72M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$486.58M+27.4%
Q1 FY2026Mar 31, 2026$530.65M+29.5%
Q4 FY2025Dec 31, 2025$533.43M+18.3%
Q3 FY2025Sep 30, 2025$352.45M+53.1%
Q2 FY2025Jun 30, 2025$382.00M+50.1%
Q1 FY2025Mar 31, 2025$409.64M+55.3%
Q4 FY2024Dec 31, 2024$450.98M+62.8%
Q3 FY2024Sep 30, 2024$230.17M-21.4%
Q2 FY2024Jun 30, 2024$254.56M+43.3%
Q1 FY2024Mar 31, 2024$263.69M+34.7%
Q4 FY2023Dec 31, 2023$276.95M+28.4%
Q3 FY2023Sep 30, 2023$292.80M+26.2%
Q2 FY2023Jun 30, 2023$177.62M-29.1%
Q1 FY2023Mar 31, 2023$195.77M-29.4%
Q4 FY2022Dec 31, 2022$215.65M-27.1%
Q3 FY2022Sep 30, 2022$232.00M-25.1%
Q2 FY2022Jun 30, 2022$250.60M-22.2%
Q1 FY2022Mar 31, 2022$277.42M-16.3%
Q4 FY2021Dec 31, 2021$295.95M-13.6%
Q3 FY2021Sep 30, 2021$309.80M–
Q2 FY2021Jun 30, 2021$322.23M–
Q1 FY2021Mar 31, 2021$331.30M–
Q4 FY2020Dec 31, 2020$342.72M–

More Olema Oncology figures

See a number that looks wrong?